GREY:ATBPF - Post by User
Post by
nozzpackon Aug 04, 2021 4:11pm
436 Views
Post# 33649707
Long history of Safety Concerns
Long history of Safety Concerns In May 2014, the company announced that it had completed pre-clinical studies on ATB-346.[7]
In late June 2014, following approval from Health Canada, the company announced the first human dosing for Phase I of its human clinical trials.[8]
In mid-January 2015, the company announced that clinical trials for its ATB-346 were being suspended due to safety concerns; clinical trials were restarted in March 2015.
So, what you are now seeing, after 6 more years, are the same safety concerns.
Lets face it.
This ultimate solution to GI side effects has been on the go since 2009.
Yet, its progression through clinical trials has not moved a single step.
That is a huge red flag that is now showing up in many fake clinical trials of drugs that, with clever promotion , can still take in the sheeple who know not what they buy.
GLTA
This is a failed drug that will never get approved due to significant safety concerns